27155979|t|Amino acid substitutions [K16A] and [K28A] distinctly affect amyloid beta-protein oligomerization.
27155979|a|Amyloid beta-protein (A beta) assembles into oligomers that play a seminal role in Alzheimer's disease (AD), a leading cause of dementia among the elderly. Despite undisputed importance of A beta oligomers, their structure and the basis of their toxicity remain elusive. Previous experimental studies revealed that the [K16A] substitution strongly inhibits toxicity of the two predominant A beta alloforms in the brain, A beta 40 and A beta 42, whereas the [K28A] substitution exerts only a moderate effect. Here, folding and oligomerization of [A16]A beta 40, [A28]A beta 40, [A16]A beta 42, and [A28]A beta 42 are examined by discrete molecular dynamics (DMD) combined with a four-bead implicit solvent force field, DMD4B-HYDRA, and compared to A beta 40 and A beta 42 oligomer formation. Our results show that both substitutions promote A beta 40 and A beta 42 oligomerization and that structural changes to oligomers are substitution- and alloform-specific. The [K28A] substitution increases solvent-accessible surface area of hydrophobic residues and the intrapeptide N-to-C terminal distance within oligomers more than the [K16A] substitution. The [K16A] substitution decreases the overall beta-strand content, whereas the [K28A] substitution exerts only a modest change. Substitution-specific tertiary and quaternary structure changes indicate that the [K16A] substitution induces formation of more compact oligomers than the [K28A] substitution. If the structure-function paradigm applies to A beta oligomers, then the observed substitution-specific structural changes in A beta 40 and A beta 42 oligomers are critical for understanding the structural basis of A beta oligomer toxicity and correct identification of therapeutic targets against AD.
27155979	26	30	K16A	ProteinMutation	tmVar:p|SUB|K|16|A;HGVS:p.K16A;VariantGroup:0;CorrespondingGene:351;CorrespondingSpecies:9606
27155979	37	41	K28A	ProteinMutation	tmVar:p|SUB|K|28|A;HGVS:p.K28A;VariantGroup:1;CorrespondingGene:351;CorrespondingSpecies:9606
27155979	121	127	A beta	Gene	351
27155979	182	201	Alzheimer's disease	Disease	MESH:D000544
27155979	203	205	AD	Disease	MESH:D000544
27155979	227	235	dementia	Disease	MESH:D003704
27155979	288	294	A beta	Gene	351
27155979	345	353	toxicity	Disease	MESH:D064420
27155979	419	423	K16A	ProteinMutation	tmVar:p|SUB|K|16|A;HGVS:p.K16A;VariantGroup:0;CorrespondingGene:351;CorrespondingSpecies:9606
27155979	456	464	toxicity	Disease	MESH:D064420
27155979	488	494	A beta	Gene	351
27155979	533	542	A beta 42	Gene	351
27155979	557	561	K28A	ProteinMutation	tmVar:p|SUB|K|28|A;HGVS:p.K28A;VariantGroup:1;CorrespondingGene:351;CorrespondingSpecies:9606
27155979	645	650	A16]A	DNAMutation	tmVar:c|SUB|A|16|A;HGVS:c.16A>A;VariantGroup:0;CorrespondingGene:351;CorrespondingSpecies:9606
27155979	661	666	A28]A	DNAMutation	tmVar:c|SUB|A|28|A;HGVS:c.28A>A;VariantGroup:1;CorrespondingGene:351;CorrespondingSpecies:9606
27155979	681	690	A beta 42	Gene	351
27155979	701	710	A beta 42	Gene	351
27155979	860	869	A beta 42	Gene	351
27155979	953	962	A beta 42	Gene	351
27155979	1066	1070	K28A	ProteinMutation	tmVar:p|SUB|K|28|A;HGVS:p.K28A;VariantGroup:1;CorrespondingGene:351;CorrespondingSpecies:9606
27155979	1172	1178	N-to-C	ProteinMutation	tmVar:p|SUB|N||C;VariantGroup:2;CorrespondingGene:351;CorrespondingSpecies:9606
27155979	1229	1233	K16A	ProteinMutation	tmVar:p|SUB|K|16|A;HGVS:p.K16A;VariantGroup:0;CorrespondingGene:351;CorrespondingSpecies:9606
27155979	1254	1258	K16A	ProteinMutation	tmVar:p|SUB|K|16|A;HGVS:p.K16A;VariantGroup:0;CorrespondingGene:351;CorrespondingSpecies:9606
27155979	1329	1333	K28A	ProteinMutation	tmVar:p|SUB|K|28|A;HGVS:p.K28A;VariantGroup:1;CorrespondingGene:351;CorrespondingSpecies:9606
27155979	1460	1464	K16A	ProteinMutation	tmVar:p|SUB|K|16|A;HGVS:p.K16A;VariantGroup:0;CorrespondingGene:351;CorrespondingSpecies:9606
27155979	1533	1537	K28A	ProteinMutation	tmVar:p|SUB|K|28|A;HGVS:p.K28A;VariantGroup:1;CorrespondingGene:351;CorrespondingSpecies:9606
27155979	1599	1605	A beta	Gene	351
27155979	1693	1702	A beta 42	Gene	351
27155979	1768	1774	A beta	Gene	351
27155979	1784	1792	toxicity	Disease	MESH:D064420
27155979	1851	1853	AD	Disease	MESH:D000544
27155979	Positive_Correlation	CorrespondingGene:351;CorrespondingSpecies:9606;VariantGroup:2;tmVar:p	HGVS:p.K28A;CorrespondingGene:351
27155979	Positive_Correlation	MESH:D000544	HGVS:p.K28A;CorrespondingGene:351
27155979	Negative_Correlation	MESH:D064420	HGVS:p.K16A;CorrespondingGene:351
27155979	Association	MESH:D064420	351
27155979	Association	MESH:D000544	351
27155979	Positive_Correlation	MESH:D000544	HGVS:p.K16A;CorrespondingGene:351
27155979	Association	MESH:D000544	351
27155979	Association	MESH:D064420	351

